agenT-797,pembrolizumab,nivolumab
mink therapeutics,bms,merck
['agent']
another presentation from #sitc2022 features mink preclinical data elucidating the novel mechanisms of allogeneic inkts. data reveal agent-797 improves the function of partially exhausted t cells, selectively kills m2 macrophages, and more. 